Marker Therapeutics Inc (MRKR)

[ash111]

Next week------>>>>> SEATTLE, May 20, 2015 /PRNewswire/ -- TapImmune (TPIV), a clinic stage Cancer Immunotherapy Company, announced today that Dr. Glynn Wilson will present at the 2015 Marcum MicroCap Conference held Wednesday, May 27, 2015 and Thursday, May 28, 2015, at the Grand Hyatt New York.

The Company's presentation by is scheduled to begin at 3.30 p.m. ET on Thursday, May 28 and will be available via a live webcast. To access the webcast, go to http://wsw.com/webcast/marcum3/tpiv. Following the presentation the webcast will be archived for 90 days.

The presentation will include an update on the progress of clinical programs. Following two successful Phase I clinical studies in HER2/neu breast cancer and ovarian and breast cancer TapImmune is completing preparations for start of Phase II trials in 2015. Please visit the Company's website at www.tapimmune.com for further details.

The annual Marcum MicroCap Conference is a showcase for public companies with less than $500 million in market capitalization. This year's keynote speaker will be Richard S. Fuld, Jr., Chairman of Matrix Adviso